Table 3 Expression of a panel of membrane markers in various histological types of breast cancer
From: Immunophenotyping invasive breast cancer: paving the road for molecular imaging
Target | Ductal (319 cases) | Lobular (126 cases) | Other (38 cases) | |||
|---|---|---|---|---|---|---|
N | % | N | % | N | % | |
HER2 | 43 | 13.5 | 4 | 3.2 | 3 | 7.9 |
EGFR | 71 | 22.3 | 4 | 3.2 | 9 | 23.7 |
MET | 34 | 10.7 | 4 | 3.2 | 5 | 13.2 |
IGF1-R | 48 | 15.0 | 7 | 5.6 | 7 | 18.4 |
GLUT1 | 85 | 26.6 | 5 | 4.0 | 8 | 21.1 |
CAIX | 38 | 11.9 | 2 | 1.6 | 6 | 15.8 |
TfR | 53 | 16.6 | 10 | 7.9 | 7 | 18.4 |
CD44v6 | 197 | 61.8 | 82 | 65.1 | 29 | 76.3 |
CAXII | 30 | 9.4 | 12 | 9.5 | 1 | 2.6 |
Mammaglobin | 44 | 13.8 | 34 | 27.0 | 3 | 7.9 |
MUC1 | 218 | 88.1 | 119 | 94.4 | 38 | 100 |